A fully funded PhD Studentship funded by @mndassoc to work on the function of TMEM106B at the synapse in ALS/FTD is available to start 1 October 2025. https://t.co/FMnG4s9GNN
Our Soak-a-Scientist event is on this Saturday at Endcliffe Park, 9-5pm! Throw a bucket of water over our scientists and learn through family-friendly interactive science experiments about the exciting research we do. @ENDPARKCAFE@Endclffeparkrun@moll_tobias@AstroMysz
How do you treat the 'cruellest disease'?
Sheffield researchers are working to make motor neurone disease (MND) history. From developing effective disease-modifying therapies to finding ways to improve the lives of MND patients.
https://t.co/s7pssSNobg
#GlobalMNDAwarenessDay
Excited to share a new publication which I had the opportunity to work on:
https://t.co/l0NvhSRcu8
This is my first published paper listed as an author and an important milestone in my career as an ECR.
Great work from everyone involved!
@AstroMysz@SarahMGranger Thanks to @mndassoc for funding this research that looks at candidate causation of TDP-43 pathology in #MND/#ALS, using CNS tissue from real human patients.
Definitely apply if you’re an ECR working on MND! It was a really fun and worthwhile event, with genuinely enjoyable networking (as someone who hates networking). 😇
The future of motor neurone disease research looks bright ✨
Last week we brought early career researchers, senior researchers and people living with and affected by #MND to connect, collaborate and develop skills. 🤝
Hear what attendees thought of the event ⬇
#MNDEnCouRageUK
“One of the early career researchers might just hold the cure in their hands and they just don’t know it yet.”
Did you hear about #MNDEnCouRageUK this week but not sure what it is? 👩🔬👨🔬
Watch below to find out why the event is so important in the fight against #MND.
That’s a wrap on #MNDEnCouRageUK 2023!
Thanks so much for all the presenters and the MND community for joining us.
And a big thanks to all the fantastic early career researchers. We are so excited to see where your careers in #MND research go in the future! 🔬🥼
What an amazing event at #MNDEnCouRageUK this week! It was a privilege to present my work and meet people living with #MND#ALS - a great reminder of what we’re all aiming to achieve in our research 👩🏻🔬
#BenevolentNews: Pleased to announce that we have progressed BEN-34712 into IND-enabling studies.
BEN-34712 is an oral, potent and selective brain penetrant RARɑ𝛃-biased agonist being developed for the potential treatment of #ALS.
Read more → https://t.co/yJJvB7qyYo
What an unbelievable moment 👏
Kevin Sinfield carries his best mate, @Rob7Burrow across the finish line of todays #RobBurrowLeedsMarathon.
Just wow 💙
Sponsor Kev here: https://t.co/SsZX6Qi8MQ
The FDA has authorised the first approved drug for a rare form of MND based on the results of a clinical trial completed at the Uni of Sheffield. This is a major scientific advance that will transform how researchers conduct MND clinical trials. https://t.co/YReIEm4FKv
Researchers around the world work tirelessly to find effective treatments for #MND#ALS 🌍
We fund cutting-edge research, and invest in the future MND leaders of tomorrow.
Sarah Granger is 1 of 22 @mndassoc PhD students who plays an invaluable role in the fight against MND.